David Mark Steinhaus

David Mark Steinhaus

Direktor/Vorstandsmitglied bei EBR SYSTEMS, INC.

Health Technology
Consumer Services
Distribution Services

Ursprung des Netzwerks ersten Grades von David Mark Steinhaus

EinheitArt der EinheitIndustrie
Public Company Medical Specialties 17
7
Holding Company Medical Specialties 7
5
Holding Company Medical Distributors 5

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von David Mark Steinhaus

UnternehmenSektorVerknüpfte PersonenHauptposition
Medical Specialties

John McCutcheon

Allan Roger Will

Michael John Hendricksen

Chief Executive Officer

Director/Board Member

Chief Tech/Sci/R&D Officer

Medical Specialties

J. Read

Chris Nave

Chairman

Director/Board Member

Investment Managers

Ilan Neugarten

Yossi Gross

Chairman

Founder

Medical Specialties

Ilan Neugarten

Yossi Gross

Chairman

Founder

Electronic Equipment/Instruments

Ilan Neugarten

Yossi Gross

Chairman

Founder

Medical Specialties

Ilan Neugarten

Yossi Gross

Director/Board Member

Founder

University of Wollongong College/University

Bronwyn Evans

Andrew Shute

Doctorate Degree

Undergraduate Degree

Medical Specialties

John McCutcheon

Michael John Hendricksen

Founder

Chief Operating Officer

Investment Managers

Dave Stassen

Allan Roger Will

Private Equity Investor

Founder

Investment Managers

J. Read

Chris Nave

Private Equity Investor

Chief Executive Officer

Technion-Israel Institute of Technology College/University

Ilan Neugarten

Yossi Gross

Undergraduate Degree

Graduate Degree

Investment Managers

Carlo Zuccaro

Chief Executive Officer

Miscellaneous Commercial Services

Leopoldo Giampaolo Zambeletti

Director/Board Member

Miscellaneous Commercial Services

Leopoldo Giampaolo Zambeletti

Corporate Officer/Principal

Biotechnology

Leopoldo Giampaolo Zambeletti

Director/Board Member

OKYO PHARMA LIMITED Biotechnology

Leopoldo Giampaolo Zambeletti

Director/Board Member

PHILOGEN S.P.A. Pharmaceuticals: Major

Leopoldo Giampaolo Zambeletti

Director/Board Member

Miscellaneous Commercial Services

Leopoldo Giampaolo Zambeletti

Director/Board Member

Financial Conglomerates

Leopoldo Giampaolo Zambeletti

Director/Board Member

Food: Major Diversified

Leopoldo Giampaolo Zambeletti

Director/Board Member

Medical Specialties

Leopoldo Giampaolo Zambeletti

Director/Board Member

Biotechnology

Leopoldo Giampaolo Zambeletti

Director/Board Member

Biotechnology

Leopoldo Giampaolo Zambeletti

Director/Board Member

Nogra Pharma Invest SARL

Leopoldo Giampaolo Zambeletti

Director/Board Member

FARON PHARMACEUTICALS OY Pharmaceuticals: Major

Leopoldo Giampaolo Zambeletti

Director/Board Member

Pharmaceuticals: Major

Chris Nave

Director/Board Member

College/University

Chris Nave

Doctorate Degree

Pharmaceuticals: Major

Chris Nave

Chairman

OSPY MEDI CDI Medical Specialties

Chris Nave

Director/Board Member

Biotechnology

Chris Nave

Chairman

BACE Therapeutics Pty Ltd.

Chris Nave

Director/Board Member

Miscellaneous Commercial Services

Chris Nave

Corporate Officer/Principal

University of California San Diego College/University

Parker N. Willis

Undergraduate Degree

Medical/Nursing Services

Madhuri Bhat

Chief Tech/Sci/R&D Officer

Pharmaceuticals: Major

Leopoldo Giampaolo Zambeletti

Director/Board Member

Biotechnology

Leopoldo Giampaolo Zambeletti

Director/Board Member

Information Technology Services

Madhuri Bhat

Founder

Medical Specialties

Yossi Gross

Founder

Medical Specialties

Yossi Gross

Founder

Massachusetts Institute of Technology College/University

Allan Roger Will

Graduate Degree

Statistik

International

Vereinigte Staaten 14
Australien 11
Israel 10
Vereinigtes Königreich 7
Irland 5

Sektoral

Health Technology 28
Finance 10
Consumer Services 5
Commercial Services 5
Electronic Technology 2

Operativ

Director/Board Member 127
Corporate Officer/Principal 40
Founder 39
Chief Executive Officer 29
Chairman 27
  1. Börse
  2. Insiders
  3. David Mark Steinhaus
  4. Unternehmensverbindungen
-40 % Einmalige Verlängerung: Unsere Abonnements führen Sie zu den besten Investitionen von morgen
PROFITIEREN SIE JETZT